Patents by Inventor CHRISTOPHER E. GILLIES

CHRISTOPHER E. GILLIES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serum metabolites as biomarkers for carnitine treatment of sepsis
    Patent number: 12478603
    Abstract: Provided herein is technology relating to treating septic shock and particularly, but not exclusively, to methods and systems for identifying sepsis patients most likely to benefit from L-carnitine treatment.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: November 25, 2025
    Assignees: The Regents of the University of Michigan, The University of Mississippi Medical Center
    Inventors: Michael A. Puskarich, Alan E. Jones, Christopher E. Gillies, Theodore S. Jennaro, Kathleen A. Stringer
  • SERUM METABOLITES AS BIOMARKERS FOR CARNITINE TREATMENT OF SEPSIS
    Publication number: 20230130325
    Abstract: Provided herein is technology relating to treating septic shock and particularly, but not exclusively, to methods and systems for identifying sepsis patients most likely to benefit from L-carnitine treatment.
    Type: Application
    Filed: March 30, 2021
    Publication date: April 27, 2023
    Inventors: Michael A. PUSKARICH, ALAN E. JONES, CHRISTOPHER E. GILLIES, THEODORE S. JENNARO, KATHLEEN A. STRINGER